A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
This study has been completed.
Study NCT00301301
Information provided by Royal Marsden NHS Foundation Trust
First Received on March 9, 2006.
Last Updated on January 11, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
